Inventor · disambiguated record
Angelo Ceci
Also filed as: CECI ANGELO
24 granted patents·22 pending applications·129 citations·filing 2001–2025
94Inventor score
Files withBOEHRINGER INGELHEIM INT22SPROUT PHARMACEUTICALS INC7CECI ANGELO5HAUEL NORBERT5BOEHRINGER INGELHEIM PHARMA4
Top patents by PatentIndex Score
46 records- 0196US7291642B2Bradykinin-B1 antagonists, process for their preparation and their use as medicamentsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Nov 6, 2007·64 cites·8 claims
- 0292US8785458B2Use of flibanserin in the treatment of obesityCECI ANGELO·Filed 2012·Granted Jul 22, 2014·15 cites·12 claims
- 0391US8227476B2Use of flibanserin in the treatment of obesityCECI ANGELO·Filed 2006·Granted Jul 24, 2012·14 cites·5 claims
- 0486US7923449B2Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disordersBOEHRINGER INGELHEIM INT·Filed 2006·Granted Apr 12, 2011·9 cites·12 claims
- 0585US8372838B2Compounds as bradykinin B1 antagonistsBOEHRINGER INGELHEIM INT·Filed 2011·Granted Feb 12, 2013·6 cites·15 claims
- 0682US9730927B2Use of flibanserin in the treatment of obesitySPROUT PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·2 cites·20 claims
- 0780US8450306B2Bradykinin B1-receptor antagonistsHAUEL NORBERT·Filed 2008·Granted May 28, 2013·5 cites·4 claims
- 0879US10849907B2Imidazopyridine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2018·Granted Dec 1, 2020·1 cites·49 claims
- 0977US10874668B2Use of Flibanserin in the treatment of obesitySPROUT PHARMACEUTICALS INC·Filed 2019·Granted Dec 29, 2020·0 cites·20 claims
- 1074US7026475B2Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Apr 11, 2006·6 cites·7 claims
- 1173US2021069185A1Use of flibanserin in the treatment of obesitySPROUT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1272US7858618B2CompoundsBOEHRINGER INGELHEIM INT·Filed 2007·Granted Dec 28, 2010·1 cites·2 claims
- 1371US11166958B24-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2019·Granted Nov 9, 2021·0 cites·31 claims
- 1470US6525045B2Positive allosteric AMPA receptor modulatorsBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Feb 25, 2003·5 cites·9 claims
- 1570US2021393644A14-Pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 1667US2025345341A14-Pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2025·Application pending·0 cites
- 1764US10335407B2Use of flibanserin in the treatment of obesitySPROUT PHARMACEUTICALS INC·Filed 2017·Granted Jul 2, 2019·0 cites·17 claims
- 1863US2015072994A1Use of Flibanserin in the Treatment of ObesityCECI ANGELO·Filed 2014·Application pending·0 cites
- 1961US11104670B24-pyrimidin-5-ylmethyl-morpholine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2019·Granted Aug 31, 2021·0 cites·11 claims
- 2061US6800623B2Method of treating schizophreniaBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Oct 5, 2004·1 cites·1 claims
- 2157US10004731B2Flibanserin for the treatment of urinary incontinence and related diseasesSPROUT PHARMACEUTICALS INC·Filed 2017·Granted Jun 26, 2018·0 cites·17 claims
- 2254US2013131075A1New compoundsHAUEL NORBERT·Filed 2013·Application pending·0 cites
- 2352US2009312242A1Flibanserin for the treatment of urinary incontinence and related diseasesCASTRO RAMIRO·Filed 2007·Application pending·0 cites
- 2451US9763936B2Flibanserin for the treatment of urinary incontinence and related diseasesSPROUT PHARMACEUTICALS INC·Filed 2015·Granted Sep 19, 2017·0 cites·17 claims
- 2551US2011046106A1Aryl sulfonamides as effective analgesicsBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 2651US2013203671A1Flibanserin for the Treatment of Urinary Incontinence and Related DiseasesSPROUT PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 2750US11155539B24-pyridinylmethyl-morpholine derivatives and the use thereof as medicamentBOEHRINGER INGELHEIM INT·Filed 2019·Granted Oct 26, 2021·0 cites·12 claims
- 2850US8916589B2Bradykinin B1-antagonistsHAUEL NORBERT·Filed 2008·Granted Dec 23, 2014·0 cites·18 claims
- 2950US8394805B2CompoundsHAUEL NORBERT·Filed 2008·Granted Mar 12, 2013·0 cites·8 claims
- 3049US2011077231A1CompoundsBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 3148US2010022558A1Treatment of insomniaBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 3248US2006211685A1Pharmaceutical compositions for the treatment and/or prevention of depressionBOEHRINGER INGELHEIM INT·Filed 2006·Application pending·0 cites
- 3348US2010240669A1New compoundsBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 3446US8937073B2Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonistsHAUEL NORBERT·Filed 2011·Granted Jan 20, 2015·0 cites·20 claims
- 3546US2009247546A1Treatment of Prevention of Valvular Heart Disease with FlibanserinBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 3646US2009176698A1Benzimidazolone Derivatives for the Treatment of Urinary IncontinenceBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 3746US2009023712A1Pharmaceutical Compositions for the Treatment of Attention Deficit Hyperactivity Disorder Comprising FlibanserinBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 3845US8865702B2B1-antagonistsKAUFFMANN-HEFNER IRIS·Filed 2008·Granted Oct 21, 2014·0 cites·22 claims
- 3944US2007123540A1Sexual desire enhancing medicaments comprising benzimidazolone derivativesCECI ANGELO·Filed 2006·Application pending·0 cites
- 4044US2006258640A1Use of Flibanserin in the treatment of chronic painBOEHRINGER INGELHEIM INT·Filed 2006·Application pending·0 cites
- 4144US2006252773A1Method for the treatment of drug abuseBOEHRINGER INGELHEIM INT·Filed 2006·Application pending·0 cites
- 4244US2003100552A1Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2002·Application pending·0 cites
- 4340US8252785B2Aryl sulfonamides as bradykinin-B1-receptor antagonistsKAUFFMANN-HEFNER IRIS·Filed 2010·Granted Aug 28, 2012·0 cites·2 claims
- 4439US2008200498A1Pharmaceutical Composition For The Treatment Of Disorders Of Sexual DesireCECI ANGELO·Filed 2006·Application pending·0 cites
- 4538US2006199805A1Pharmaceutical compositions for the treatment and/or prevention of anxiety disordersBOEHRINGER INGELHEIM INT·Filed 2006·Application pending·0 cites
- 4638US2006204486A1Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseasesBOEHRINGER INGELHEIM INT·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Angelo Ceci files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →